Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.050
+0.020 (1.94%)
Feb 18, 2026, 4:00 PM EST - Market closed
Rockwell Medical Market Cap
Rockwell Medical has a market cap or net worth of $41.38 million as of February 18, 2026. Its market cap has decreased by -37.21% in one year.
Market Cap
41.38M
Enterprise Value
30.79M
1-Year Change
-37.21%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since December 1, 1998, Rockwell Medical's market cap has increased from $7.80M to $41.38M, an increase of 430.46%. That is a compound annual growth rate of 6.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 40.60M | 23.40% |
| Dec 31, 2025 | 32.90M | -50.08% |
| Dec 31, 2024 | 65.90M | 22.49% |
| Dec 29, 2023 | 53.80M | 355.93% |
| Dec 30, 2022 | 11.80M | -69.35% |
| Dec 31, 2021 | 38.50M | -59.26% |
| Dec 31, 2020 | 94.50M | -39.46% |
| Dec 31, 2019 | 156.10M | 21.20% |
| Dec 31, 2018 | 128.80M | -57.24% |
| Dec 29, 2017 | 301.20M | -10.76% |
| Dec 30, 2016 | 337.50M | -35.47% |
| Dec 31, 2015 | 523.00M | 16.69% |
| Dec 31, 2014 | 448.20M | 7.33% |
| Dec 31, 2013 | 417.60M | 143.50% |
| Dec 31, 2012 | 171.50M | 8.48% |
| Dec 30, 2011 | 158.10M | 14.57% |
| Dec 31, 2010 | 138.00M | 5.18% |
| Dec 31, 2009 | 131.20M | 126.21% |
| Dec 31, 2008 | 58.00M | -30.54% |
| Dec 31, 2007 | 83.50M | 2.08% |
| Dec 29, 2006 | 81.80M | 108.14% |
| Dec 30, 2005 | 39.30M | 46.10% |
| Dec 31, 2004 | 26.90M | -20.88% |
| Dec 31, 2003 | 34.00M | 608.33% |
| Dec 31, 2002 | 4.80M | -47.25% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 93.17M |
| Assertio Holdings | 79.41M |
| Cumberland Pharmaceuticals | 58.03M |
| InterCure | 49.40M |
| Zhengye Biotechnology Holding | 45.59M |
| Talphera | 37.79M |
| BioXcel Therapeutics | 34.55M |
| SCYNEXIS | 31.47M |